Nosopharm
PrivateLast Round
Debt
Feb 12, 2018
Total Funding Raised
$1.2M
Company Overview
Nosopharm is a biotechnology company that specializes in the research and development of new anti-infective drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nosopharm Comparables
Compare Nosopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antabio | 83% | |
| VenatoRx Pharmaceuticals | 76% | |
| Bioversys | 76% |
Nosopharm Funding Rounds
Historical fundraising activity
Nosopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alto Invest | VC Round |
| Kreaxi | VC Round |
| Région Occitanie | Grant |
| Auriga Partners | VC Round |
| Bpifrance | Grant, Debt |
| Direction générale de l'armement (DGA) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2018
$1.2M round led by Bpifrance
- Mar 28, 2017
Raised $2.6M from Alto Invest, Auriga Partners, and Kreaxi.
Nosopharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nosopharm's valuation, stock price, and market status.
Is Nosopharm a public or private company?
Nosopharm is a private company.
What is the current stock price of Nosopharm?
Nosopharm is a private company, so its shares have no public market price. Caplight tracks Nosopharm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nosopharm worth (valuation)?
Valuation information for Nosopharm is not publicly available.
Can I buy Nosopharm stock?
Nosopharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nosopharm's last funding round?
Nosopharm's most recent funding round was Debt on February 12, 2018.
Who are the main investors in Nosopharm?
Key investors in Nosopharm include Bpifrance.
Will Nosopharm IPO soon?
No public IPO plans have been announced for Nosopharm.
How can I track Nosopharm secondary market activity?
Caplight tracks bids, offers, and trades in Nosopharm's shares on secondary markets.